Abstract-The machine learning techniques are playing a major role in the field of immunoinformatics for DNA-binding domain analysis. Functional analysis of the binding ability of DNA-binding domain protein antigen peptides to major histocompatibility complex (MHC) class molecules is important in vaccine development. The variable length of each binding peptide complicates this prediction. Such predictions can be used to select epitopes for use in rational vaccine design and to increase the understanding of roles of the immune system in infectious diseases. Antigenic epitopes of DNA-binding domain protein form Human papilloma virus-31 are important determinant for protection of many host form viral infection. This study shows active part in host immune reactions and involvement of MHC class-I and MHC II in response to almost all antigens. We used PSSM and SVM algorithms for antigen design, which represented predicted binders as MHCII-IAb, MHCII-IAd, MHCII-IAg7, and MHCII-RT1.B nonamers from viral DNA-binding domain crystal structure. These peptide nonamers are from a set of aligned peptides known to bind to a given MHC molecule as the predictor of MHC-peptide binding. Analysis shows potential drug targets to identify active sites against diseases.
INTRODUCTION
Human papillomavirus (HPV) is a papillomavirus that infects the skin and mucous membranes of humans, epithelia of humans and animals, where they generally induce benign proliferation at the site of infection. Also, in some cases the lesions induced by certain papillomaviruses undergo malignant progression. There is a strong association between malignant progression of human genital lesions and certain human papillomavirus (HPV) types, such as HPV16. The cervical carcinomas contain and express HPV early genes, and these genes have been shown to have potent transforming and immortalizing activity in cultured cells. The virus is made up of many and varied strains that differ in a number of aspects including host range, symptoms, and means of transmission (Sénéchal, et al 2007; Davidson, et al 2004) . The strains of DNA-binding domain protein are differentiated on the basis of symptoms on indicator host. Viral DNA-binding domain protein is central to the establishment of viral pathogenesis, and yet relatively little is understood about the structural and functional aspects of protein or about the host factors on which they depend. DNA-binding domain protein and the genetic material necessary for its production in; an exemption from the requirement of a tolerance is established for residues of the biological viral therapy (Wang, et al 2004; Gomase, et al 2008a; Gomase, et al 2007) . (Gomase, et al 2006; Reche, et al 2002; Buus et al 2003; Nielsen et al 2003; Bhasin and Raghava 2005) . In addition, we predicted machine learning based MHC ligands from whose C-terminal end is likely to be the result of proteosomal cleavage. (Fig. 9, 10 ) and unstructured, antibodies against those regions are also likely to recognize the native protein ( Fig. 1-4) . It was shown that DNA-binding domain protein is hydrophobic in nature and contains segments of low complexity and high-predicted flexibility (Fig. 5-8 ). Predicted antigenic fragments can bind to MHC molecule is the first bottlenecks in vaccine design. 
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